The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. Prog Neurobiol. 2015;127-128:1-22. doi: 10.1016/j.pneurobio.2015.02.003.

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

Heidi Crayton, MD, and Maria Lopes, MD, discuss the impact of multiple sclerosis on patients, families, and caregivers, differentiate relapsing forms (relapsing-remitting and primary progressive ...

And unlike secondary multiple sclerosis, which arises after many years of RRMS, PPMS is an initial diagnosis. The symptoms and pathophysiology of PPMS differ from other forms, too.

Associations of White Matter and Basal Ganglia Microstructure to Cognitive Fatigue Rate in Multiple Sclerosis. Frontiers in Neurology , 2022; 13 DOI: 10.3389/fneur.2022.911012 Cite This Page : ...

If you have trouble speaking or swallowing, speech-language pathology can help. Takeaways. Late-onset multiple sclerosis is a form of the disease in which symptoms develop after age 50.

Considering the longevity of astrocytes, and their multiple contributions to CNS pathology, the authors suggest that astrocyte immune memory might be a possible mechanism behind chronic neurologic ...

More information: Matthew R. Brier et al, Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients, Annals of Neurology (2024). DOI: 10.1002/ana.27027.

TOPLINE: Amyloid pathology typical of Alzheimer's disease (AD) is 50% lower in patients with multiple sclerosis (MS) than in those without the condition, an analysis of plasma biomarker data shows ...

I've been involved in MS care since before any treatments were available. I’m chief operating officer at Can Do Multiple Sclerosis, a nonprofit in the patient advocacy sphere of MS. I’m also a ...